To include your compound in the COVID-19 Resource Center, submit it here.

Allos falls as Folotyn sales miss

Allos Therapeutics Inc. (NASDAQ:ALTH) fell $0.26 to $2.59

Read the full 81 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE